RCT-evaluation of Retzius-sparing Robotic Prostatectomy
Robotic Retzius-sparing Radical Prostatectomy- a Randomized Controlled Trial Evaluating Transdouglas-RARP
1 other identifier
interventional
186
1 country
1
Brief Summary
Prospective randomized blinded RCT comparing Transdouglas Prostatectomy to classical transperitoneal anterior radical prostatectomy
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable prostate-cancer
Started Aug 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 27, 2018
CompletedFirst Submitted
Initial submission to the registry
September 4, 2018
CompletedFirst Posted
Study publicly available on registry
December 26, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2020
CompletedMarch 24, 2020
March 1, 2020
2 years
September 4, 2018
March 23, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Urinary continence
Pad use
1 Week after Prostatectomy
Secondary Outcomes (4)
Resection margine
pathology report, approximately 1 week postoperatively
Urinary continence
3, 6 and 12 months after Prostatectomy
Postoperative complications
First 12 months after Prostatectomy
postoperative PSA
12 months
Study Arms (2)
Retzius-sparing RARP
OTHERArm B randomizes men with an indication for radical robotic Prostatectomy (RARP) to retzius-sparing transdouglas RARP
anterior transperitoneal RARP
OTHERArm A randomizes men with an indication for radical robotic Prostatectomy (RARP) to anterior transperitoneal RARP
Interventions
Modification of robotic Prostatectomy Arm A classic technique/ anterior transperitoneal RARP Arm B Transdouglas Technique/retzius-sparing RARP
Eligibility Criteria
You may qualify if:
- Indication for radical prostatectomy
- \>18 years old
- Literate
- Preoperatively continent
- informed signed consent for study
You may not qualify if:
- cT4-Cancer
- Withdrawl of consent to study
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Heidelberg
Heidelberg, Germany
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Chief senior physician and Vice chairlady of the Dept. of Urology
Study Record Dates
First Submitted
September 4, 2018
First Posted
December 26, 2018
Study Start
August 27, 2018
Primary Completion
August 31, 2020
Study Completion
November 30, 2020
Last Updated
March 24, 2020
Record last verified: 2020-03